Hospital Acquired Infection Control Market Reaches US$ 6.6 Billion in 2022, Set to Hit US$ 10.1 Billion by 2033: Persistence Market Research

The global Hospital Acquired Infection Control Market is on a steady growth trajectory, projected to expand at a compound annual growth rate (CAGR) of 3.9% over the next decade. From a market value of US$ 6.6 billion in 2022, the sector is forecast to reach US$ 10.1 billion by 2033, according to recent data compiled by Persistence Market Research.

This upward momentum comes amid growing awareness of healthcare-associated infections (HAIs), robust government programs for infection prevention, and the expansion of healthcare infrastructure, particularly in emerging economies. As of 2023, disinfection equipment dominates the product category, holding a 50.3% share of the global market.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/2814

Decade-Long Growth Driven by Infection Awareness and Technological Advancements

The past decade (2012-2022) witnessed a 4.8% CAGR, reflecting increasing demand for sterilization and disinfection tools. The surging prevalence of chronic and infectious diseases and the global emphasis on safer healthcare environments have catalyzed the adoption of advanced infection control systems.

Moreover, COVID-19 served as a critical inflection point, heightening awareness around hospital infection control systems. The pandemic exposed the vulnerability of healthcare systems to rapid infection transmission and highlighted the indispensable role of sterilization and disinfection technologies in mitigating risks. Following the outbreak, hospitals and governments worldwide reinforced infection control standards, creating fertile ground for manufacturers to innovate and expand.

Key Drivers Shaping Market Dynamics

1. Surging Surgical Procedures

An increase in the number of surgical procedures globally continues to drive demand for sterilized medical tools and disinfection equipment. By the end of the decade, surgical interventions are expected to hit an all-time high, directly influencing the need for HAI control equipment.

2. Chronic Disease Burden

A rise in the prevalence of chronic diseases, particularly in aging populations, has led to longer hospital stays and repeated interventions, both of which elevate the risk of nosocomial infections. This has strengthened the case for comprehensive infection control frameworks in hospitals.

3. Technological Innovation

Startups and established players alike are investing heavily in cutting-edge technologies. For instance, PURioLABS, a Texas-based company, has introduced a compact disinfection cabinet that sterilizes equipment in seconds. Similarly, Unimech Healthcare launched its UniClean range featuring UVGI and cloud-connected solutions, showcasing the integration of IoT into disinfection protocols.

Market Limitations and Challenges

Despite positive momentum, several barriers continue to hinder optimal market expansion:

Complex Reprocessing Needs: Instruments such as endoscopes require rigorous sterilization processes. Reprocessing inefficiencies can result in infection outbreaks, posing a persistent challenge for healthcare providers.

Infrastructure Gaps in Developing Regions: Inadequate infection control infrastructure and limited availability of advanced disinfection equipment in developing countries constrain market reach.

Regional Insights: Where is the Growth Coming From?

United States: Market Leader with a 33.9% Global Share

The U.S. continues to dominate the HAI control landscape, driven by a sophisticated healthcare system, strong regulatory mandates, and high infection awareness. Surveys conducted in 183 U.S. hospitals revealed that 4% of hospitalized patients had at least one hospital-acquired infection-most commonly Clostridium difficile and pneumonia-reinforcing the demand for stringent infection control practices.

China: Rising Public Awareness and Government Initiatives

With a 5.5% global market share in 2022, China is emerging as a crucial market due to increasing awareness of HAIs and government-backed infection prevention programs. Diseases such as hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are prevalent, prompting hospitals to invest in advanced disinfection systems.

India: Untapped Potential Amidst Healthcare Expansion

India's share stood at 3.4% in 2022, but it is poised for robust growth as the country's healthcare system modernizes. Rising hygiene awareness, a growing population, and government-backed healthcare reforms are expected to significantly elevate demand for infection control solutions.

Product and End-User Analysis

Disinfection Equipment: The Leading Product Segment

Valued for its ease of use, cost-effectiveness, and efficacy, disinfection equipment is projected to hold a 50.3% share in 2023. This dominance is attributed to increased surgical procedures, more healthcare facilities, and greater attention to infection risks associated with reusable medical equipment.

Hospitals: Primary End Users

Hospitals accounted for a 32.1% market share in 2023, primarily due to the high volume of surgical procedures and long-term patient care. The rising geriatric population and higher rates of chronic illness necessitate stringent infection control in these environments.

Competitive Landscape: A Fragmented Yet Dynamic Industry

The market remains highly fragmented, with numerous global and regional players competing on innovation, pricing, and service. Major companies continue to pursue mergers, acquisitions, and product launches to strengthen their foothold.

Notable Developments:

STERIS Plc acquired Cantel Medical in 2021, boosting its infection control portfolio across dental and life sciences sectors.

UVision360 Inc. received regulatory approval in July 2021 to expand reprocessing practices for the LUMINELLE DTx System, aiming at broader hospital use.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/2814

Key Players:

Olympus Corporation

Medivators Inc. (Cantel Medical Corp.)

Getinge Group

STERIS Plc.

Belimed AG

Pfizer Inc.

F. Hoffmann-La Roche Ltd

Merck & Co.

Johnson & Johnson (ASP Services Inc.)

Abbott Laboratories

3M Company

Bayer AG

Cepheid Inc.

UVision360 Inc.

Future Outlook and Strategic Opportunities

The hospital-acquired infection control market stands at the crossroads of necessity and innovation. With a projected market value of US$ 10.1 billion by 2033, companies have the opportunity to address rising global health challenges through proactive solutions and scalable technologies.

Growth strategies such as cloud-based disinfection systems, AI-driven hygiene analytics, and portable sterilization units are likely to define the next wave of innovation. Moreover, as healthcare delivery shifts toward ambulatory and outpatient care, infection control solutions tailored to non-hospital settings will see increased demand.

Conclusion

As the global healthcare ecosystem becomes more intricate and patient safety takes center stage, hospital acquired infection control will continue to be a top priority. Robust growth, fueled by innovation and heightened awareness, sets the stage for transformative change in how healthcare facilities combat infections.

For stakeholders-manufacturers, healthcare providers, policymakers, and investors-the next decade presents a crucial window to innovate, expand, and safeguard global health against the threat of hospital-acquired infections.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.